Skip to main content

Want a detailed portfolio tracker?

Assembly Biosciences (ASMB) P/E (2011 - 2026)

Assembly Biosciences (ASMB) P/E from Jun 30, 2011 to Jul 21, 2026. The TTM Assembly Biosciences (ASMB) P/E is -24.30. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Assembly Biosciences (ASMB)

YearP/EChange
2026-24.30+19.72%
2025-20.30+711.76%
2024-2.50+332.68%
2023-0.58+20.75%
2022-0.48-41.05%
2021-0.81-75.09%
2020-3.26-83.59%
2019-19.86-67.31%
2018-60.75-50.01%
2017-121.52+272.43%
2016-32.63+61.78%
2015-20.17-4.45%
2014-21.11+430.69%
2013-3.98-85.23%
2012-26.92-73.03%
2011-99.81N/A

Comparison Assembly Biosciences (ASMB) P/E with competitors

Assembly Biosciences (ASMB) P/E is -24.30.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.31%
FGENFibroGen Inc0.24-100.99%
CHRSCoherus Biosciences Inc0.85-103.49%
FBIOFortress Biotech Inc0.95-103.91%
ORMPOramed Pharmaceuticals Inc1.50-106.18%
AGENAgenus Inc3.01-112.38%
INVAInnoviva Inc3.15-112.98%
VXRTVaxart Inc3.55-114.61%
CRMDCorMedix Inc3.63-114.93%
CVACCureVac N.V.4.45-118.29%
GLPGGalapagos NV4.86-119.99%
SRPTSarepta Therapeutics Inc4.88-120.09%
ABEOAbeona Therapeutics Inc5.39-122.17%
ABUSArbutus Biopharma Corp5.60-123.03%
ZVRAZevra Therapeutics Inc5.89-124.23%
SPROSpero Therapeutics Inc6.23-125.63%
CGENCompugen Ltd6.31-125.98%
RIGLRigel Pharmaceuticals6.87-128.28%
SLXNSilexion Therapeutics Corp7.30-130.02%
OMEROmeros Corporation9.26-138.10%
AUPHAurinia Pharmaceuticals Inc9.58-139.44%
PLXProtalix BioTherapeutics Inc10.89-144.81%
ACADAcadia Pharmaceuticals Inc11.73-148.26%
TBPHTheravance Biopharma Inc12.26-150.46%
ADMAAdma Biologics Inc12.42-151.10%
HRMYHarmony Biosciences Holdings Inc13.82-156.87%
SABSSAB Biotherapeutics Inc14.14-158.17%
NAGENiagen Bioscience Inc14.82-160.97%
INCYIncyte Corp15.82-165.11%
REGNRegeneron Pharmaceuticals Inc15.86-165.25%
PBYIPuma Biotechnology Inc17.32-171.25%
CPRXCatalyst Pharmaceuticals Inc17.44-171.76%
EXELExelixis Inc17.54-172.17%
TGTXTG Therapeutics Inc18.97-178.04%
MDXGMimedx Group Inc20.55-184.57%
XOMAXOMA Royalty Corp22.87-194.13%
ARGXArgen X SE24.30-199.99%
CTMXCytomX Therapeutics Inc24.82-202.14%
XOMAOXOMA Royalty Corp25.34-204.29%
HALOHalozyme Therapeutics Inc25.62-205.44%
XOMAPXOMA Royalty Corp25.67-205.63%
VRTXVertex Pharmaceuticals Inc27.99-215.20%
RPRXRoyalty Pharma plc - Class A28.69-218.05%
SLNOSoleno Therapeutics Inc29.02-219.40%
ASNDAscendis Pharma A/S30.09-223.80%
LGNDLigand Pharmaceuticals Inc - Class B37.91-256.01%
APLSApellis Pharmaceuticals Inc39.02-260.57%
BMRNBiomarin Pharmaceutical Inc42.21-273.70%
KRYSKrystal Biotech Inc45.34-286.59%
ONCBeiGene Ltd69.54-386.16%
PHARPharming Group N.V.75.03-408.73%
TECHBio-Techne Corp101.96-519.56%
VCELVericel Corp109.92-552.32%
ALNYAlnylam Pharmaceuticals Inc117.96-585.42%
GMABGenmab140.29-677.29%
TLXTelix Pharmaceuticals Ltd162.15-767.25%
CORTCorcept Therapeutics Inc212.86-975.90%